Related Experiment Videos
Erythrocyte choline concentrations in psychiatric disorders.
A L Stoll1, B M Cohen, I Hanin
1Clinical and Molecular Pharmacology Laboratory, McLean Hospital Mailman Research Center, Belmont, MA 02178.
Biological Psychiatry
|February 15, 1991
Summary
Erythrocyte choline levels are often elevated in neuropsychiatric disorders, particularly in specific patient subgroups. Lithium therapy significantly increases erythrocyte choline, potentially predicting treatment response.
Area of Science:
- Neuroscience
- Biochemistry
- Psychiatry
Background:
- Erythrocyte choline serves as an indirect biomarker for central nervous system (CNS) cholinergic function.
- Neuropsychiatric disorders are complex conditions affecting brain function and behavior.
Purpose of the Study:
- To review literature and present new data on erythrocyte choline concentrations in neuropsychiatric disorders.
- To explore the relationship between erythrocyte choline levels, clinical characteristics, and lithium therapy response.
Main Methods:
- Literature review of studies on erythrocyte choline in neuropsychiatric conditions.
- Analysis of new data on erythrocyte choline concentrations in patient cohorts.
- Comparison of erythrocyte choline levels between patients and controls.
Main Results:
- Mean erythrocyte choline concentrations are modestly elevated in patients with affective illnesses, psychoses, and dementia compared to controls.
- Elevated erythrocyte choline levels are often driven by subgroups with particularly high concentrations.
- These subgroups exhibit distinct clinical characteristics.
- Lithium therapy induces a significant increase in erythrocyte choline concentration.
Conclusions:
- Erythrocyte choline may serve as a valuable biomarker in neuropsychiatric disorders.
- Identifying subgroups with elevated erythrocyte choline could aid in understanding disease mechanisms.
- Erythrocyte choline levels, especially in response to lithium, may predict treatment outcomes.